COVID-19 Treatment: GSK Sotrovimab, Roche antibody cocktail casirivimab-imdevimab no longer recommended by WHO Ruchika Sharma22 Sept 2022 4:14 PM ISTBoth therapies continue to be recommended for use by the European drugs regulator.
GSK-Vir COVID therapy Sotrovimab authorization junked by USFDA Roshni Dhar8 April 2022 11:17 AM ISTThe U.S. health regulator said on Tuesday GlaxoSmithKline and Vir Biotechnology's antibody therapy was no longer authorized as a COVID-19 treatment,...
Health Bulletin 7/April/2022 Roshni Dhar7 April 2022 5:51 PM ISTHere are the top health stories for today: Health Ministry denies detection of XE variant in India In response to the media reports that...
USFDA junks authorization of GSK- Vir COVID therapy Sotrovimab Ruchika Sharma6 April 2022 4:20 PM ISTSotrovimab is no longer authorized to treat COVID-19 in any US region due to increases in the proportion of COVID-19 cases caused by the Omicron BA.2...
Scientists, drugmakers start the hunt for long COVID treatments Ruchika Sharma27 March 2022 9:00 AM ISTNew Delhi: After producing vaccines and treatments for acute COVID-19 in record time, researchers and drugmakers are turning to finding a cure for...
WHO panel recommends Eli Lilly Baricitinib, GSK-Vir Biotechnology drug for COVID treatment Ruchika Sharma14 Jan 2022 3:59 PM ISTNew Delhi: The World Health Organization on Friday gave a nod to two new drugs for the treatment of COVID-19 patients with severe and non-severe...
Tests show Covid antibody drug effective against Omicron: GSK MD Bureau5 Dec 2021 10:00 AM ISTLondon: British drugmaker GlaxoSmithKline has claimed that early laboratory tests show that its antibody drug against Covid-19 is effective against...
GSK, Vir Biotechnology submit EUA request to USFDA for VIR-7831 for early Covid-19 treatment Ruchika Sharma28 March 2021 10:30 AM ISTLondon and San Francisco: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced the submission of an application to the U.S. Food...
GSK, Vir Biotechnology to halt enrollment in US COVID-19 antibody trial sub-study Ruchika Sharma4 March 2021 3:50 PM ISTNew Delhi: Vir Biotechnology and Britain's GSK said on Wednesday they would pause enrollment into a study testing their experimental COVID-19 antibody...
GSK, Vir Biotechnology expand coronavirus collaboration to include new therapies including influenza Ruchika Sharma20 Feb 2021 9:30 AM ISTLondon: GlaxoSmithKline plc and Vir Biotechnology, Inc. have recently announced they have signed a binding agreement to expand their existing...
